4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
SCYNEXIS, Inc. (SCYX) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Jersey City, United States with about 18 employees. Its market capitalization is roughly $363 million. In the fiscal year ended 2025-12-31, SCYX reported $21M in revenue and ($9M) in net income.
SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States.
Interactive charts & full statements → Open the SCYX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $21M | $4M | $140M | $5M | — |
| Gross Profit | — | $4M | $124M | $4M | $13M |
| Operating Income (EBIT) | ($16M) | ($37M) | $73M | ($86M) | — |
| Net Income | ($9M) | ($21M) | $67M | ($63M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $19M | $0M | $1M | $0M | — |
| Gross Profit | — | — | — | — | — | $1M |
| Operating Income (EBIT) | ($17M) | $10M | ($8M) | ($10M) | ($9M) | — |
| Net Income | ($21M) | $12M | ($9M) | ($7M) | ($5M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $59M | $91M | $128M | $88M | — |
| Total Liabilities | $10M | $36M | $56M | $85M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SCYX viewer.
About TickerBase · Data methodology & sources